- Report
- October 2024
- 191 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 194 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- July 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- January 2025
- 185 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- December 2023
- 130 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- January 2022
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- October 2024
- 87 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
The In Vitro Lung Model market is a subset of the In Vitro Diagnostics (IVD) industry. It is composed of products and services used to simulate the human lung in a laboratory setting. These models are used to study the effects of drugs, toxins, and other substances on the respiratory system. They are also used to develop new treatments and therapies for respiratory diseases.
In Vitro Lung Models are typically composed of a combination of cell cultures, organoids, and 3D printed scaffolds. These models are used to study the effects of drugs, toxins, and other substances on the respiratory system. They are also used to develop new treatments and therapies for respiratory diseases.
The In Vitro Lung Model market is highly competitive, with many companies offering a variety of products and services. Some of the major players in the market include Thermo Fisher Scientific, Merck KGaA, PromoCell, Lonza, and Corning. Show Less Read more
